LSTA - Lisata Therapeutics, Inc.

Stock Grade Analysis

General Rating

C
Overall Score: 2/5
Multi-dimensional Scores
DCF: 4/5 ROE: 1/5 ROA: 1/5 D/E: 1/5 P/E: 1/5
Financial Ratios Trend

Grades Consensus

0

Strong Buy

0

Buy

2

Hold

0

Sell

0

Strong Sell

Hold

Consensus

Grade News & Updates

Date Grading Company New Grade Previous Grade Action Price When Posted News Title Publisher
2026-05-15 H.C. Wainwright Neutral Buy Downgrade $3.17 Lisata Therapeutics downgraded to Neutral from Buy at H.C. … TheFly
2024-09-18 H.C. Wainwright Buy Buy Hold $3.1 H.C. Wainwright Reiterates Buy Rating on Lisata Therapeutic… StreetInsider